ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $444,000 | +2511.8% | 16,625 | -73.6% | 0.67% | +2206.9% |
| Q2 2017 | $17,000 | -98.0% | 63,000 | -45.2% | 0.03% | -97.4% |
| Q1 2017 | $839,000 | +129.9% | 114,934 | +293.7% | 1.10% | +163.5% |
| Q4 2016 | $365,000 | -20.0% | 29,193 | -78.2% | 0.42% | +15.7% |
| Q3 2016 | $456,000 | -54.1% | 133,800 | -19.5% | 0.36% | -57.5% |
| Q2 2016 | $993,000 | +53.7% | 166,299 | +34.7% | 0.85% | +25.8% |
| Q1 2016 | $646,000 | +136.6% | 123,496 | +517.5% | 0.68% | +235.1% |
| Q4 2015 | $273,000 | – | 20,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |